0001415889-25-014257.txt : 20250522 0001415889-25-014257.hdr.sgml : 20250522 20250522183925 ACCESSION NUMBER: 0001415889-25-014257 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250520 FILED AS OF DATE: 20250522 DATE AS OF CHANGE: 20250522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farnum Rhonda CENTRAL INDEX KEY: 0001898490 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36033 FILM NUMBER: 25978673 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theravance Biopharma, Inc. CENTRAL INDEX KEY: 0001583107 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 650-808-6000 MAIL ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 4 1 form4-05222025_100521.xml X0508 4 2025-05-20 0001583107 Theravance Biopharma, Inc. TBPH 0001898490 Farnum Rhonda C/O THERAVANCE BIOPHARMA US, LLC 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 false true false false SVP, COMM & MEDICAL AFFAIRS 0 Ordinary Shares 2025-05-20 4 F 0 9120 9.45 D 360918 D Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. /s/ Brett A. Grimaud, Attorney-in-Fact 2025-05-22